Cargando…
Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria
Background: Nitisinone-induced hypertyrosinaemia is well documented in Alkaptonuria (AKU), and there is uncertainty over whether it may contribute to a decline in cognitive function and/or mood by altering neurotransmitter metabolism. The aim of this work was to evaluate the impact of nitisinone on...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230570/ https://www.ncbi.nlm.nih.gov/pubmed/35736410 http://dx.doi.org/10.3390/metabo12060477 |
_version_ | 1784735093342863360 |
---|---|
author | Davison, Andrew S. Norman, Brendan P. Sutherland, Hazel Milan, Anna M. Gallagher, James A. Jarvis, Jonathan C. Ranganath, Lakshminarayan R. |
author_facet | Davison, Andrew S. Norman, Brendan P. Sutherland, Hazel Milan, Anna M. Gallagher, James A. Jarvis, Jonathan C. Ranganath, Lakshminarayan R. |
author_sort | Davison, Andrew S. |
collection | PubMed |
description | Background: Nitisinone-induced hypertyrosinaemia is well documented in Alkaptonuria (AKU), and there is uncertainty over whether it may contribute to a decline in cognitive function and/or mood by altering neurotransmitter metabolism. The aim of this work was to evaluate the impact of nitisinone on the cerebrospinal fluid (CSF) metabolome in a murine model of AKU, with a view to providing additional insight into metabolic changes that occur following treatment with nitisinone. Methods: 17 CSF samples were collected from BALB/c Hgd(−/−) mice (n = 8, treated with nitisinone—4 mg/L and n = 9, no treatment). Samples were diluted 1:1 with deionised water and analysed using a 1290 Infinity II liquid chromatography system coupled to a 6550 quadrupole time-of-flight mass spectrometry (Agilent, Cheadle, UK). Raw data were processed using a targeted feature extraction algorithm and an established in-house accurate mass retention time database. Matched entities (±10 ppm theoretical accurate mass and ±0.3 min retention time window) were filtered based on their frequency and variability. Experimental groups were compared using a moderated t-test with Benjamini–Hochberg false-discovery rate adjustment. Results: L-Tyrosine, N-acetyl-L-tyrosine, γ-glutamyl-L-tyrosine, p-hydroxyphenylacetic acid, and 3-(4-hydroxyphenyl)lactic acid were shown to increase in abundance (log2 fold change 2.6–6.9, 3/5 were significant p < 0.05) in the mice that received nitisinone. Several other metabolites of interest were matched, but no significant differences were observed, including the aromatic amino acids phenylalanine and tryptophan, and monoamine metabolites adrenaline, 3-methoxy-4-hydroxyphenylglycol, and octopamine. Conclusions: Evaluation of the CSF metabolome of a murine model of AKU revealed a significant increase in the abundance of a limited number of metabolites following treatment with nitisinone. Further work is required to understand the significance of these findings and the mechanisms by which the altered metabolite abundances occur. |
format | Online Article Text |
id | pubmed-9230570 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92305702022-06-25 Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria Davison, Andrew S. Norman, Brendan P. Sutherland, Hazel Milan, Anna M. Gallagher, James A. Jarvis, Jonathan C. Ranganath, Lakshminarayan R. Metabolites Article Background: Nitisinone-induced hypertyrosinaemia is well documented in Alkaptonuria (AKU), and there is uncertainty over whether it may contribute to a decline in cognitive function and/or mood by altering neurotransmitter metabolism. The aim of this work was to evaluate the impact of nitisinone on the cerebrospinal fluid (CSF) metabolome in a murine model of AKU, with a view to providing additional insight into metabolic changes that occur following treatment with nitisinone. Methods: 17 CSF samples were collected from BALB/c Hgd(−/−) mice (n = 8, treated with nitisinone—4 mg/L and n = 9, no treatment). Samples were diluted 1:1 with deionised water and analysed using a 1290 Infinity II liquid chromatography system coupled to a 6550 quadrupole time-of-flight mass spectrometry (Agilent, Cheadle, UK). Raw data were processed using a targeted feature extraction algorithm and an established in-house accurate mass retention time database. Matched entities (±10 ppm theoretical accurate mass and ±0.3 min retention time window) were filtered based on their frequency and variability. Experimental groups were compared using a moderated t-test with Benjamini–Hochberg false-discovery rate adjustment. Results: L-Tyrosine, N-acetyl-L-tyrosine, γ-glutamyl-L-tyrosine, p-hydroxyphenylacetic acid, and 3-(4-hydroxyphenyl)lactic acid were shown to increase in abundance (log2 fold change 2.6–6.9, 3/5 were significant p < 0.05) in the mice that received nitisinone. Several other metabolites of interest were matched, but no significant differences were observed, including the aromatic amino acids phenylalanine and tryptophan, and monoamine metabolites adrenaline, 3-methoxy-4-hydroxyphenylglycol, and octopamine. Conclusions: Evaluation of the CSF metabolome of a murine model of AKU revealed a significant increase in the abundance of a limited number of metabolites following treatment with nitisinone. Further work is required to understand the significance of these findings and the mechanisms by which the altered metabolite abundances occur. MDPI 2022-05-25 /pmc/articles/PMC9230570/ /pubmed/35736410 http://dx.doi.org/10.3390/metabo12060477 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Davison, Andrew S. Norman, Brendan P. Sutherland, Hazel Milan, Anna M. Gallagher, James A. Jarvis, Jonathan C. Ranganath, Lakshminarayan R. Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria |
title | Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria |
title_full | Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria |
title_fullStr | Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria |
title_full_unstemmed | Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria |
title_short | Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria |
title_sort | impact of nitisinone on the cerebrospinal fluid metabolome of a murine model of alkaptonuria |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230570/ https://www.ncbi.nlm.nih.gov/pubmed/35736410 http://dx.doi.org/10.3390/metabo12060477 |
work_keys_str_mv | AT davisonandrews impactofnitisinoneonthecerebrospinalfluidmetabolomeofamurinemodelofalkaptonuria AT normanbrendanp impactofnitisinoneonthecerebrospinalfluidmetabolomeofamurinemodelofalkaptonuria AT sutherlandhazel impactofnitisinoneonthecerebrospinalfluidmetabolomeofamurinemodelofalkaptonuria AT milanannam impactofnitisinoneonthecerebrospinalfluidmetabolomeofamurinemodelofalkaptonuria AT gallagherjamesa impactofnitisinoneonthecerebrospinalfluidmetabolomeofamurinemodelofalkaptonuria AT jarvisjonathanc impactofnitisinoneonthecerebrospinalfluidmetabolomeofamurinemodelofalkaptonuria AT ranganathlakshminarayanr impactofnitisinoneonthecerebrospinalfluidmetabolomeofamurinemodelofalkaptonuria |